Felix Hilpert

Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial

Éric Pujade-Lauraine, Felix Hilpert, B. Weber et al. · Journal of Clinical Oncology · 2014 · 1.6K citations · Full text

Medicine, Oncology, Pharmacology +17

A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms

Philipp Harter, Jalid Sehouli, Domenica Lorusso et al. · New England Journal of Medicine · 2019 · 600 citations · Full text

Medicine, Oncology, Surgery +15

Adjuvant Therapy in Lymph Node–Positive Vulvar Cancer: The AGO-CaRE-1 Study

Sven� Mahner, J Jueckstock, Felix Hilpert et al. · JNCI Journal of the National Cancer Institute · 2015 · 229 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

Andreas du Bois, Gunnar B. Kristensen, Isabelle Ray‐Coquard et al. · The Lancet Oncology · 2015 · 209 citations · Full text

Medicine, Gynecology, Oncology +11

Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential

Ivo Meinhold‐Heerlein, Dirk Bauerschlag, Felix Hilpert et al. · Oncogene · 2004 · 205 citations

Medicine, Oncology, Pathology +16